Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1.03M Buy
14,825
+1,269
+9% +$94.2K 0.31% 77
2022
Q1
$1.04M Buy
13,556
+5,890
+77% +$424K 0.2% 107
2021
Q4
$587K Buy
7,666
+3,182
+71% +$234K 0.11% 171
2021
Q3
$331K Buy
+4,484
New +$336K 0.06% 259
2015
Q2
Sell
-25
Closed 220
2015
Q1
$0 Buy
+25
New +$767 ﹤0.01% 453

Other funds holding HOLX

Intersect Capital's HOLX Position: Q2 2022 in Review

Intersect Capital increased its Hologic (HOLX) stake by 9.4% in Q2 2022, buying an estimated $94.2K and bringing the position to 14,825 shares worth $1.03M. The position accounts for 0.31% of the portfolio, ranked #77.

Intersect Capital first reported a position in HOLX in Q1 2015 and has held it in 5 quarters since. The position peaked at $1.04M in Q1 2022. 694 funds tracked by Wall St. Rank hold HOLX as of Q2 2022.

  • Intersect Capital held 14,825 shares of Hologic worth $1.03M as of Q2 2022.
  • Intersect Capital bought 1,269 Hologic shares in Q2 2022, an estimated $94.2K.
  • Hologic made up 0.31% of Intersect Capital's portfolio in Q2 2022, its #77 holding.
  • Intersect Capital first reported a position in Hologic in Q1 2015 and has held it in 5 quarters since.
  • Intersect Capital's Hologic position peaked at $1.04M in Q1 2022.
  • 694 funds tracked by Wall St. Rank held Hologic as of Q2 2022.

Based on Intersect Capital's 13F filing for Q2 2022, filed 2 Sep 2022.